Methylphenidate and cocaine: A placebo-controlled drug interaction study

Pharmacology Biochemistry and Behavior

Volumn 85, Issue 1, 2006, Pages 29-38

  Winhusen, Theresa ^a   Somoza, Eugene ^a,b   Singal, Bonita M ^a   Harrer, Judy ^a   Apparaju, Sandhya ^c   Mezinskis, Juris ^a,b   Desai, Pankaj ^c   Elkashef, Ahmed ^d   Chiang, C Nora ^d   Horn, Paul ^b,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Cardiovascular effects; Cocaine; Cocaine pharmacokinetics; Methyphenidate; Subjective effects

Indexed keywords

COCAINE; METHYLPHENIDATE;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; FEMALE; HEADACHE; HOSPITAL ADMISSION; HUMAN; INFORMED CONSENT; MALE; NERVOUSNESS; NORMAL HUMAN; OUTPATIENT; PRIORITY JOURNAL; SIDE EFFECT; SKIN TINGLING; THORAX PAIN; VISUAL ANALOG SCALE; VITAL SIGN;

ADULT; COCAINE; CROSS-OVER STUDIES; DRUG INTERACTIONS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; MALE; METHYLPHENIDATE; MIDDLE AGED; PLACEBOS;

EID: 33751078575     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.06.023     Document Type: Article

References (28)

1. Biederman J., Faraone S., Spencer T., Wilens T., Norman D., Lapey K., et al. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with Attention Deficit Hyperactivity Disorder. Am J Psychiatry 150 (1993) 1792-1798
2. Bosron W., Dean R., Brzezinski M., and Pindel E. Human liver cocaine carboxylesterases. In: Rapaka R.S., Chiang N., and Martin B.R. (Eds). Pharmacokinetics, Metabolism and Pharmaceutics of Drugs of Abuse. NIDA Research Monograph vol. 173 (1997) 27-33 Washington DC
3. Chow M.J., Ambre J.J., Ruo T.I., Atkinson Jr. A.J., Bowsher D.J., and Fischman M.W. Kinetics of cocaine distribution, elimination and chronotropic effects. Clin Pharmacol Ther 38 (1985) 318-324
4. Collins S., Levin F., Foltin R., Kleber H., and Evans S. Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD. Drug Alcohol Depend 82 (2006) 158-167
5. Cone E.J., Kumor K., Thompson L.K., and Sherer M. Correlation of saliva cocaine levels with plasma levels and with pharmacologic effects after intravenous cocaine administration in human subjects. J Anal Toxicol 12 (1988) 200-206
6. Gawin F., Riordan C., and Kleber H. Methylphenidate treatment of cocaine abusers without attention deficit disorder: a negative report. Am J Drug Alcohol Abuse 11 (1985) 193-197
7. Goldfrank L., and Hoffman R. The cardiovascular effects of cocaine. Ann Emerg Med 20 (1991) 165-175
8. Grabowski J., Roache J., Schmitz J., Rhoades H., Creson D., and Korszun A. Replacement medication for cocaine dependence; methylphenidate. J Clin Psychopharmacol 17 (1997) 485-488
9. Greenhill L., Halperin J., and Abikoff H. Stimulant medications. J Am Acad Child Adolesc Psych 38 (1999) 503-512
10. Gualtieri C.T., Wargin W., Kanoy R., Patrick K., Shen C.D., Youngblood W., et al. Clinical studies of methylphenidate serum levels in children and adults. J Am Acad Child Psychiatry 21 (1982) 19-26
11. Hart C.L., Jatlow P., Sevarino K.A., and McCance-Katz E.F. Comparison of intravenous cocaethylene and cocaine in humans. Psychopharmacology 149 (2000) 153-162
12. Hoffman B., and Lefkowitz R. Catecholamines, sympathomimetic drugs and anticholinergic receptor antagonists. In: Gilman A.G., Hardman J., and Limbird L. (Eds). Goodman and Gilman's, Pharmacologic Basis of Therapeutics. 9th ed. (1996), McGraw Hill, New York 199-248
13. Kimko H.C., Cross J.T., and Abernethy D.R. Pharmacokinetics and clinical effectiveness of methylphenidate. Drug Dispos 37 (1999) 457-470
14. Laizure S., Williams C., and Parker R. Predominant pathway of cocaine metabolism unknown. Am J Emerg Med 13 (1995) 250
15. Levin F., Evans S., McDowell D., and Kleber H. Methylphenidate treatment of cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychiatry 59 (1998) 300-305
16. Lin S., Andrenyak D., Moody D., and Foltz R. Enantioselective gas chromatography/negative ion chemical ionization mass spectrometry for methylphenidate in human plasma. J Anal Toxicol 23 (1999) 524-530
17. Lin S., Moody D., Bigelow G., and Foltz R. A validated liquid chromatography atmospheric pressure chemical ionization-tandem mass spectrometric method for quantitation of cocaine and benzoylecgonine in human plasma. J Anal Toxicol 25 (2001) 497-503
18. Llana M., and Crismon M. Methylphenidate: increased abuse or appropriate use?. J Am Pharm Assoc (Wash.) 39 (1999) 526-530
19. Parker R., Laizure S., Williams C., Mandrell T., and Lima J. Evaluation of dose-dependent pharmacokinetics of cocaethylene and cocaine in conscious dogs. Life Sci 62 (1998) 333-342
20. Roache J., Grabowski J., Schmitz J., Creson D., and Rhoades H. Laboratory measures of methylphenidate effects in cocaine-dependent patients receiving treatment. J Clin Psychopharmacol 20 (2000) 61-68
21. Rush C., and Baker R. Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers. Exp Clin Psychopharmacol 9 (2001) 59-73
22. Schachter H., Pham B., King J., Langford S., and Moher D. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. Can Med Assoc J 165 (2001) 1475-1488
23. Schenk S., and Izenwasser S. Pretreatment with methylphenidate sensitizes rats to the reinforcing effects of cocaine. Pharmacol Biochem Behav 72 (2002) 651-657
24. Schubiner H., Saules K., Arfken C., Johanson C., Schuster C., Lockhart N., et al. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol 10 (2002) 286-294
25. Somoza E., Winhusen T., Bridge P., Rotrosen J., Vanderburg D., Harrer J., et al. An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder. J Addict Dis 23 (2004) 77-92
26. Spencer T., Wilens T., Biederman J., Faraone S., Ablon J., and Lapey K. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry 52 (1995) 434-443
27. StatSoft, Inc. STATISTICA (data analysis software system), version 6.1. www.statsoft.com, 2004.
28. Wilens T., Faraone S., and Biederman J. Attention-Deficit/Hyperactivity Disorder in adults. JAMA 292 (2004) 619-623